|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Efficacy of melphalan and predni- sone puls thalidomide in patients older than 75 years with newly diag- nosed multiple myeloma 显示文摘 | Hulin C Facon T Rodon P | 2009 | Clin Oncol2009，27，22： | 1 |
| 2 | Development of PARP inhibitors in ontology 显示文摘 | RODON J IN1ESTA MD PAPADOPOULOS K | 2009 | Expert Opin lnvestig Drugs2009，18，1： | 1 |
| 3 | How will HPV vaccines affect cervical cancer 显示文摘 | Rodon R Wu TC | 2006 | Nature Rev2006，，6： | 1 |
| 4 | Picking the point of inhibition: a comparative review of PI3K/AKT/mTOR pathway inhibitors 显示文摘 | Dienstmarm R Rodon J Serra V | 2014 | Molecular cancer therapeutics2014，13，5： | 1 |
| 5 | Phase I,dose-escalation study of BKM120, an oral pan-Class I PI3Kinhibitor, in patients with advanced solid tumors 显示文摘 | Bendell JC Rodon J Burris HA | 2012 | J ClinOncol2012，30，3： | 1 |
| 6 | Efficacy of melphalan and prednisone plus thalidomide in patients older than 75 years with newly diagnosed multiple myeloma显示文摘 | Hulin C Facon T Rodon P | 2009 | J Clin Oncol2009，27，22： | 1 |
| 7 | Phase Ⅰ,dose-escalation study of BKM 120,an oral pan-Class Ⅰ P13K inhibitor,in patients with advanced solid tumors显示文摘 | Bendell JC Rodon J Burris HA | 2012 | J Clin Oncol2012，30，3： | 1 |
| 8 | First-in-human dose study of the Novel transforming growth factor-β receptor Ⅰ kinase inhibitor LY2157299 monohydrate in patients with advanced cancer and glioma显示文摘 | Rodon J Carducci MA Sepulveda-Sanchez JM | 2014 | Clin Cancer Res2014，，： | 1 |
| 9 | Pilot studies for personalized cancer medicine: focusing on the patient for treatment selec; tion 显示文摘 | De Mattos-Arruda L Rodon J | 2013 | Oncologist2013，18，11： | 1 |
| 10 | A phase I pharmaeokinetie study of bexarotene with paelitaxel and carboplatin in patients with advanced non-small cell lung cancer (NSCLC) 显示文摘 | Jordi Rodon Charlotte D | 2012 | Caneer chemotherapy and pharmacology2012，69，3： | 1 |
| 11 | Phase I, dose- escalation study of BKM120, an oral pan-Class I PI3K inhibitor, in patients with advanced solid tumors显示文摘 | Bendell JC Rodon J Burris H A | 2012 | Journal of Clinical Oncology2012，30，3： | 1 |
| 12 | Efficacy of melphalan and prednisone plus thalidomide in patients older than 75 years with newly diagnosed multiple myelomaa:IFM 01/01 trial显示文摘 | Hulin C Facon T Rodon P | 2009 | J Clin Oncol2009，27，22： | 1 |
| 13 | Granular- bed filtration assisted by filter-cake formation 2 : the panel bed gas filter with puffback renewal of gas-en- try surfaces显示文摘 | RODON I LEE K C PEFFER R | 2005 | Powder Technology2005，155，1： | 1 |
| 14 | Nearly zero inclination geosynchronous SAR mission analysis with long integration time for earth observation 显示文摘 | RUIZ RODON J BROQUETAS A MAKHOUL E | 2014 | IEEE Transactions of Geoscience and Remote Sensing2014，52，10： | 1 |
| 15 | How will HPV vaccines affect cervical cancer 显示文摘 | Rodon R Wu TC | 2006 | Nature Rev Cancer2006，6，10： | 1 |
| 16 | A first-in-human phase Ⅰ study of BKM120,an oral pan-class I PI3K inhibitor,in patients (pts) with advanced solid tumors显示文摘 | Baselga J Rodon J Burris HA | | 0，，15： | 1 |
| 17 | First in-human phase Ⅰ study of the oral PI3K inhibitor BEZ235 in patients (pts) with advanced solid tumors显示文摘 | Baselga J Jonge DE Rodon J | | 0，，15： | 1 |
| 18 | Phase; , dose-escala tion study of BKM120, an oral pan-Class I PI3K inhibitor, in patients with advanced solid tumors显示文摘 | Bendell JC Rodon J Burris HA | 2012 | J Clin Oncol2012，30，3： | 1 |
| 19 | A process-stake-holder analysis of B2B industry standardization显示文摘 | Rodon J Ramis-Pujol J Christiaanse E | 2007 | Jour-nal of Enterprise Information Management2007，20，1： | 1 |
| 20 | A phase I pharmacokinetic study of bexarotene with paclitaxel and carboplatin in pa tients with advanced non-small cell lung eaneer(NSCLC)显示文摘 | Jordi Rodon Charlotte D | 2012 | Cancer Chemotherapy and Pharmacology2012，69，3： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员